Tag: ENROUTE stent

Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTEĀ® Transcarotid Stent System

SUNNYVALE, Calif., May 02, 2022 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that that the U.S. Food and Drug Administration (FDA) approved expanded indications for the ENROUTE stent to include patients at standard […]